Executive Order 14293 Act of 2025
HR 3676, the Executive Order 14293 Act of 2025, would make Executive Order 14293 a permanent law with the force of law. This executive order provides regulatory relief to encourage domestic production of critical medicines by streamlining certain approval processes. The bill directly affects pharmaceutical manufacturers and the U.S. drug supply chain by turning these regulatory changes into legally binding requirements. Its key mechanism is codifying the executive order, ensuring the policy changes cannot be reversed by future executive actions.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jun 2025
Committee Review
Floor Vote
President
Introduced Jun 3, 2025
Last action Jun 3, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jun 3, 2025
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Jun 3, 2025
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 3676
Scope: US
Hi! I can help you understand HR 3676. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline